{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:05:02Z","timestamp":1782453902000,"version":"3.54.5"},"reference-count":13,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1128\/aac.01988-15","type":"journal-article","created":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T02:21:18Z","timestamp":1441765278000},"page":"7156-7157","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":7,"title":["Enterococcus faecalis-Related Prostatitis Successfully Treated with Moxifloxacin"],"prefix":"10.1128","volume":"59","author":[{"given":"Beno\u00eet","family":"Pilmis","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris Descartes, Sorbonne Paris Cit\u00e9, Centre d'Infectiologie Necker-Pasteur, H\u00f4pital Necker-Enfants Malades, IHU Imagine, Paris, France"},{"name":"Equipe Mobile de Microbiologie Clinique, Groupe Hospitalier Paris Saint-Joseph, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"L\u00e9cuyer","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes, Sorbonne Paris Cit\u00e9, Service de Microbiologie, H\u00f4pital Necker-Enfants Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes, Sorbonne Paris Cit\u00e9, Centre d'Infectiologie Necker-Pasteur, H\u00f4pital Necker-Enfants Malades, IHU Imagine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Charlier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes, Sorbonne Paris Cit\u00e9, Centre d'Infectiologie Necker-Pasteur, H\u00f4pital Necker-Enfants Malades, IHU Imagine, Paris, France"},{"name":"Institut Pasteur, Biology of Infection Unit, Paris, France"},{"name":"Inserm U1117, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/652861"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000074526"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-5347(17)61919-0","article-title":"Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid","volume":"103","author":"Stamey TA","year":"1970","unstructured":"Stamey TA, Meares EM, Winningham DG. 1970. Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J Urol 103:187\u2013194.","journal-title":"J Urol"},{"key":"e_1_3_1_5_2","unstructured":"EUCAST. 2014. Breakpoint tables for interpretation of MICs and zone diameters. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/Breakpoint_table_v_4.0.pdf."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(03)00565-X"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.08.025"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2007.11.003"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7349.1306"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/375078"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis664"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2009.06.004"},{"key":"e_1_3_1_13_2","volume-title":"Moxifloxacin (Avelox) prescribing information","author":"FDA","year":"2002","unstructured":"FDA. 2002. Moxifloxacin (Avelox) prescribing information. FDA, Silver Spring, MD. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2002\/21085s12lbl.pdf."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku283"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01988-15","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01988-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:42:50Z","timestamp":1645483370000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01988-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1128\/AAC.01988-15"],"URL":"https:\/\/doi.org\/10.1128\/aac.01988-15","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"2015-10-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}